PhRMA's Tauzin links drug innovation to US economic recovery
This article was originally published in Scrip
Executive Summary
Maintaining pharmaceutical industry innovation is critical to any future economic recovery in the US, PhRMApresident and CEO Billy Tauzin says. He suggests that major healthcare reform proposals which impede the industry's ability or incentive to develop new medicines will only add to the country's current economic woes.